StonvexLoading…
StonvexStonvexStonvexCore line items from OKE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $9.62B | $33.63B | $24.56B | $15.93B |
Operating Income | $1.43B | $5.74B | $4.21B | $2.65B |
Net Income | $774.00M | $3.39B | $2.42B | $1.48B |
EPS (Diluted) | $1.23 | $5.42 | $3.87 | $2.38 |
Total Assets | $68.20B | $66.64B | $66.62B | $64.52B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $172.00M | $78.00M | $1.20B | $97.00M |
Free Cash Flow OCF − CapEx | $70.00M | $2.45B | $1.87B | $1.05B |
Shares Outstanding | 630.03M | 629.71M | 629.84M | 629.75M |